Asymmetric dimethylarginine (ADMA) a novel cardiovascular risk factor--evidence from epidemiological and prospective clinical trials.
Year: 2006
Type: article
Source: PubMed
Authors: Andrzej Szuba, Maciej Podgórski
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2409376413
